To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STRBPandC9orf45TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
410 supporting clones for gene STRBPandC9orf45 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU183094 melanotic melanoma, skin .a 1 to 835 1 to 842   tiling clone,   842/877
(96 %)
15 diff
(98.3 %id)
AK027890   .a 21 to 2560 1 to 2540 exact tiling clone, available from FLJ,   2540/2540
(100 %)
1 diff
(100.0 %id)
DB126910 thymus .a 22 to 360 2 to 340   capped   339/339
(100 %)
2 diff
(99.5 %id)
DB294062   .a 22 to 801 2 to 781   capped   780/780
(100 %)
1 diff
(99.9 %id)
DB462514 testis .a 32 to 508 1 to 477       477/477
(100 %)
0 diff
(100 %id)
DB501086 hypothalamus .a 41 to 519 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
BC108731 Eye, retinoblastoma .a 46 to 2127 1 to 2082   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2082/2091
(99 %)
4 diff
(99.9 %id)
BU179067 eye, retinoblastoma .a 47 to 935 1 to 894       894/894
(100 %)
10 diff
(98.9 %id)
DA711925   .a 54 to 422 2 to 371   capped   370/377
(98 %)
2 diff
(99.5 %id)
BQ961434 leiomyosarcoma, uterus .a 64 to 532 12 to 480       469/1356
(34 %)
14 diff
(99.0 %id)
BQ225405 epithelioid carcinoma, Pancreas .a 70 to 661 1 to 598       598/954
(62 %)
9 diff
(99.1 %id)
DA625890 Kidney .a 84 to 629 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA780728 brain .a 84 to 660 2 to 581   capped   580/580
(100 %)
4 diff
(99.4 %id)
DA773385 brain .a 89 to 657 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA291587 hippocampus .a 118 to 701 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CN393407 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 128 to 757 1 to 630       630/630
(100 %)
4 diff
(99.4 %id)
TI_154195653   .a 132 to 974 21 to 858       838/1033
(81 %)
13 diff
(98.8 %id)
BI118160 lung, small cell carcinoma .a 160 to 749 1 to 587       587/739
(79 %)
17 diff
(97.7 %id)
BX353039 Neuroblastoma Cot 10-normalized .a 200 to 902 1 to 703       703/703
(100 %)
0 diff
(100 %id)
DB384032   .a 2065 to 2560 501 to 1       501/546
(91 %)
15 diff
(97.3 %id)
BX353038 Neuroblastoma Cot 10-normalized .a 2310 to 2736 425 to 1   tiling clone,   425/425
(100 %)
9 diff
(97.9 %id)
BC017732 Uterus, leiomyosarcoma .b 1 to 3005 1 to 3003 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3003/3003
(100 %)
2 diff
(100.0 %id)
NM_018387.4   .b 1 to 6415 1 to 6415 exact RefSeq, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 6415/6415
(100 %)
0 diff
(100 %id)
DA689340   .b 10 to 476 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
BG754362 B-cells, primary B-cells from tonsils (cell line) .b 51 to 645 1 to 588       588/589
(99 %)
10 diff
(98.4 %id)
DB022681 testis .b 149 to 696 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AL515178 neuroblastoma, placenta .b 261 to 1000 1 to 743       739/743
(99 %)
19 diff
(97.5 %id)
CD693557 normal nasopharynx .b 263 to 871 78 to 686       609/686
(88 %)
6 diff
(99.2 %id)
CD299947 testis .b 263 to 963 70 to 775       706/930
(75 %)
14 diff
(98.5 %id)
DA644384   .b 267 to 703 154 to 591   capped   438/590
(74 %)
1 diff
(99.9 %id)
BP220595 colon .b 276 to 846 1 to 571       571/571
(100 %)
5 diff
(99.2 %id)
CD644610 Embryonic Stem cells .b 279 to 1063 12 to 788       777/845
(91 %)
19 diff
(97.8 %id)
CN393401 embryonic stem cells, cell lines H1, H7, andH9 .b 292 to 891 1 to 600       600/600
(100 %)
0 diff
(100 %id)
CN393403 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 346 to 951 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
AF333337 testis .b 404 to 2831 1 to 2431 L173I E174G K175R K176R D177K ... AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2431/2433
(99 %)
8 diff
(99.7 %id)
BP260860 small intestine .b 412 to 991 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BM829446 Ascites, stomach .b 420 to 1054 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
CV023778 mixed .b 431 to 1085 1 to 654       654/654
(100 %)
3 diff
(99.6 %id)
AL515177 neuroblastoma, placenta .b 2518 to 3337 818 to 1   tiling clone,   818/818
(100 %)
19 diff
(97.7 %id)
AL136866 testis .c 1 to 2988 1 to 2988 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2988/2988
(100 %)
1 diff
(100.0 %id)
NM_001171137.1   .c 1 to 6398 1 to 6398 exact RefSeq, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 6398/6398
(100 %)
0 diff
(100 %id)
CN393406 embryonic stem cells, DMSO-treated H9 cellline .c 10 to 187 1 to 178       178/178
(100 %)
4 diff
(97.8 %id)
DR432386 mixed .c 416 to 1082 8 to 674       667/674
(98 %)
11 diff
(98.4 %id)
DR433005 mixed .c 416 to 1086 8 to 678       671/678
(98 %)
6 diff
(99.2 %id)
DR433303 mixed .c 416 to 1089 8 to 680       673/680
(98 %)
10 diff
(98.6 %id)
DR432539 mixed .c 416 to 1203 8 to 793       786/831
(94 %)
14 diff
(98.4 %id)
DR432716 mixed .c 416 to 1122 8 to 715       708/812
(87 %)
9 diff
(98.9 %id)
DR432663 mixed .c 416 to 1088 8 to 679       672/679
(98 %)
9 diff
(98.7 %id)
TI_1948081623   .c 416 to 948 129 to 661       533/1172
(45 %)
10 diff
(99.2 %id)
TI_1948081624   .c 416 to 1342 134 to 1067       934/1316
(70 %)
37 diff
(97.2 %id)
TI_1948081846   .c 416 to 953 130 to 668       539/1160
(46 %)
25 diff
(97.9 %id)
TI_1948081847   .c 416 to 1249 132 to 968       837/1341
(62 %)
18 diff
(98.7 %id)
TI_1948082271   .c 416 to 1038 127 to 754       628/1253
(50 %)
24 diff
(98.1 %id)
TI_1948082272   .c 416 to 1080 131 to 798       667/1477
(45 %)
16 diff
(99.0 %id)
CN393405 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 417 to 1127 1 to 711       711/711
(100 %)
1 diff
(99.9 %id)
BX456625 thymus .c 430 to 1234 1 to 804       804/804
(100 %)
1 diff
(99.9 %id)
BG388848 embryonal carcinoma, cell line, testis .c 452 to 1241 1 to 789       789/885
(89 %)
16 diff
(98.2 %id)
DA691099   .c 454 to 1027 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BM904147 lymph, lymphoma, cell line .c 467 to 1424 1 to 963       963/1045
(92 %)
13 diff
(98.8 %id)
AL046465 testis .c 469 to 663 1 to 195       195/195
(100 %)
7 diff
(96.5 %id)
BG259160 embryonal carcinoma, cell line, testis .c 487 to 1248 1 to 759       759/763
(99 %)
23 diff
(97.0 %id)
BQ440741 melanotic melanoma, skin .c 536 to 1346 1 to 818       818/915
(89 %)
8 diff
(99.2 %id)
BG746930 adenocarcinoma cell line, colon .c 583 to 1168 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BC002693 Uterus, endometrium adenocarcinoma .c 585 to 2606 1 to 2022   available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2022/2022
(100 %)
0 diff
(100 %id)
BU599333 mixed (pool of 40 RNAs) .c 588 to 1386 1 to 800       800/808
(99 %)
21 diff
(97.5 %id)
BE388898 endometrium, adenocarcinoma cell line, uterus .c 604 to 1161 1 to 558   available from MGC,   558/558
(100 %)
0 diff
(100 %id)
BF026831 melanotic melanoma, skin .c 604 to 1216 1 to 613       613/613
(100 %)
6 diff
(99.1 %id)
BF960615 nervous_normal .c 642 to 769 1 to 129       129/134
(96 %)
10 diff
(92.6 %id)
BF960069 nervous_normal .c 643 to 775 1 to 134       134/143
(93 %)
10 diff
(93.1 %id)
BG340757 B-cells, primary B-cells from tonsils (cell line) .c 645 to 1318 1 to 677       677/886
(76 %)
13 diff
(98.6 %id)
DA753174   .c 711 to 1264 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA511017 brain .c 713 to 1292 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
AA215781 germinal center B cell .c 744 to 1001 1 to 260       259/260
(99 %)
3 diff
(98.9 %id)
BG121796 adenocarcinoma, cell line, Liver .c 754 to 1519 1 to 760       760/946
(80 %)
26 diff
(97.3 %id)
BU940988 mixed (pool of 40 RNAs) .c 769 to 1468 1 to 703       703/781
(90 %)
15 diff
(98.1 %id)
BP196504 adrenal gland .c 778 to 1358 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BE869021 adenocarcinoma, colon .c 788 to 1559 1 to 765       765/1111
(68 %)
22 diff
(98.1 %id)
BP265222 thyroid .c 803 to 1379 4 to 579       576/579
(99 %)
6 diff
(99.0 %id)
BM451327 eye, retinoblastoma .c 805 to 1737 1 to 941       939/1005
(93 %)
15 diff
(98.6 %id)
BP260695 small intestine .c 840 to 1415 1 to 575       575/575
(100 %)
4 diff
(99.4 %id)
BP261339 small intestine .c 840 to 1421 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BG535195 lung .c 855 to 1335 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
CB135362 Liver .c 902 to 1409 1 to 508       508/508
(100 %)
0 diff
(100 %id)
DN992585 brain, whole brain .c 925 to 1570 3 to 648       646/648
(99 %)
8 diff
(98.8 %id)
AK002169 placenta .c 957 to 2814 1 to 1858   tiling clone, available from FLJ,   1858/1858
(100 %)
1 diff
(100.0 %id)
AU139159 placenta .c 958 to 1645 2 to 691   capped   690/690
(100 %)
3 diff
(99.6 %id)
BP366720 thymus .c 984 to 1566 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BE566338 bladder, carcinoma, cell line .c 996 to 1631 1 to 648       609/651
(93 %)
23 diff
(96.5 %id)
BG427259 Kidney .c 1105 to 1754 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
BM554275 brain, medulla .c 1108 to 2127 11 to 1033       1023/1036
(98 %)
22 diff
(97.9 %id)
AL041636 testis .c 1117 to 1662 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
AK024285   .c 1146 to 3318 1 to 2174   tiling clone, available from FLJ,   2174/2174
(100 %)
1 diff
(100.0 %id)
AU132215   .c 1147 to 1983 2 to 834   capped   833/833
(100 %)
4 diff
(99.6 %id)
BG775460 carcinoma, cell line, Prostate .c 1169 to 1778 613 to 3       611/613
(99 %)
6 diff
(99.1 %id)
BG291824 bladder, transitional cell papilloma, cell line .c 1220 to 1755 1 to 538       538/940
(57 %)
9 diff
(99.1 %id)
CX872244 embryonic stem .c 1259 to 2047 1 to 789       789/789
(100 %)
1 diff
(99.9 %id)
AF012373 testis .c 1283 to 1607 1 to 325       325/325
(100 %)
0 diff
(100 %id)
AA056347 colon, tumor .c 1318 to 1591 1 to 280     Submitted on the opposite strand 278/286
(97 %)
12 diff
(95.9 %id)
CF140922 CNCAP(3)T-225 cell line, Prostate .c 1329 to 1702 8 to 381       374/381
(98 %)
7 diff
(98.2 %id)
TI_154171572   .c 1329 to 2046 80 to 800       721/944
(76 %)
15 diff
(98.5 %id)
AA984061 schizophrenic brain S-11 frontal lobe .c 1335 to 1952 1 to 618     Submitted on the opposite strand 618/618
(100 %)
12 diff
(98.1 %id)
BE542868 cervix .c 1374 to 1906 1 to 533       533/533
(100 %)
1 diff
(99.9 %id)
TI_154171912   .c 1385 to 2046 85 to 752   AAA   668/1068
(62 %)
17 diff
(98.5 %id)
CF141229 CNCAP(3)T-225 cell line, Prostate .c 1388 to 1944 11 to 567       557/567
(98 %)
6 diff
(99.0 %id)
BG315203   .c 1401 to 1597 197 to 1       197/197
(100 %)
0 diff
(100 %id)
BP337972 Spleen .c 1454 to 2035 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DW444971 Liver .c 1465 to 1678 10 to 224       215/224
(95 %)
8 diff
(96.5 %id)
BU959768 mixed (pool of 40 RNAs) .c 1489 to 2100 1 to 607       607/767
(79 %)
11 diff
(98.6 %id)
AV748343 Pituitary .c 1520 to 1842 1 to 323       323/330
(97 %)
7 diff
(97.9 %id)
DW428354 Liver .c 1532 to 1791 17 to 276       260/276
(94 %)
6 diff
(97.9 %id)
H58691.
matches multiple genes
liver and spleen .c 1552 to 1963 415 to 3     Submitted on the opposite strand, also hits gene PGK1 413/469
(88 %)
1 diff
(99.8 %id)
TI_1948082064   .c 1561 to 2436 996 to 126       871/1122
(77 %)
31 diff
(97.3 %id)
TI_1948081625   .c 1564 to 2436 977 to 118       860/1098
(78 %)
31 diff
(97.2 %id)
N53133 liver and spleen .c 1580 to 1964 391 to 1       391/396
(98 %)
12 diff
(97.0 %id)
TI_1948082273   .c 1637 to 2436 839 to 45       795/1008
(78 %)
14 diff
(98.7 %id)
DR432536 mixed .c 1641 to 2431 790 to 6       785/790
(99 %)
11 diff
(98.7 %id)
AA157675 colon, tumor .c 1691 to 2097 1 to 413       413/415
(99 %)
12 diff
(97.2 %id)
AW969193   .c 1693 to 2185 1 to 493       493/497
(99 %)
1 diff
(99.8 %id)
BE537527 cervix .c 1703 to 2357 1 to 655       655/1151
(56 %)
13 diff
(98.9 %id)
CN390998 embryonic stem cells, cell lines H1, H7, andH9 .c 1707 to 2410 12 to 715       704/715
(98 %)
6 diff
(99.2 %id)
CK825073 Pancreas, Purified pancreatic islet .c 1707 to 2300 1 to 594     Submitted on the opposite strand 594/594
(100 %)
3 diff
(99.5 %id)
BM272507 Pancreas, Purified pancreatic islet .c 1722 to 2220 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BU164305 large cell carcinoma, lung .c 1728 to 2619 12 to 919       908/925
(98 %)
40 diff
(95.7 %id)
DR432718 mixed .c 1752 to 2431 683 to 6       678/756
(89 %)
12 diff
(98.5 %id)
TI_1948081848   .c 1782 to 2436 769 to 109       661/1103
(59 %)
27 diff
(97.6 %id)
DR433301 mixed .c 1783 to 2431 654 to 6       649/654
(99 %)
0 diff
(100 %id)
DR432661 mixed .c 1784 to 2431 653 to 6       648/653
(99 %)
2 diff
(99.7 %id)
DR432384 mixed .c 1786 to 2431 651 to 6       646/651
(99 %)
0 diff
(100 %id)
AA533251 invasive prostate tumor, Prostate .c 1789 to 2320 1 to 530       530/614
(86 %)
12 diff
(98.1 %id)
DR433003 mixed .c 1790 to 2431 647 to 6       642/647
(99 %)
0 diff
(100 %id)
TI_149301560   .c 1809 to 2626 876 to 59       818/998
(81 %)
9 diff
(99.1 %id)
CR621060 Neuroblastoma Cot 25-normalized .c 1823 to 2813 1 to 991       991/991
(100 %)
0 diff
(100 %id)
AL525679 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1823 to 2808 1 to 983   fully sequenced,   983/983
(100 %)
10 diff
(99.0 %id)
FN172936 breast carcinoma .c 1826 to 1900 7 to 83       77/83
(92 %)
6 diff
(92.8 %id)
AL046440 testis .c 1828 to 2022 1 to 195       195/195
(100 %)
1 diff
(99.5 %id)
BG113333 Bone, osteosarcoma, cell line .c 1828 to 2555 1 to 731       731/732
(99 %)
6 diff
(99.2 %id)
BX281323 Bone, osteosarcoma, cell line .c 1844 to 2296 1 to 454       454/456
(99 %)
5 diff
(99.0 %id)
T99670 liver and spleen .c 1848 to 2125 1 to 283       283/328
(86 %)
8 diff
(97.6 %id)
DR422559 eye, Pterygium .c 1868 to 2586 1 to 719       719/719
(100 %)
1 diff
(99.9 %id)
T39198 lung .c 1871 to 2126 1 to 256       256/273
(93 %)
7 diff
(97.5 %id)
BP294077 Liver .c 1878 to 2470 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BM979986 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1904 to 2606 720 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 702/702
(100 %)
2 diff
(99.8 %id)
BG194908   .c 1909 to 2601 1 to 688   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 688/692
(99 %)
11 diff
(98.5 %id)
AW070938 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .c 1913 to 2605 689 to 1       689/692
(99 %)
12 diff
(98.3 %id)
BM931563 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1973 to 2341 1 to 369   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
BM272280 Pancreas, Purified pancreatic islet .c 1986 to 2605 619 to 1       619/619
(100 %)
5 diff
(99.2 %id)
TI_149273846   .c 2006 to 2606 686 to 86   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 601/883
(68 %)
0 diff
(100 %id)
BE093352 breast .c 2020 to 2394 376 to 1     Submitted on the opposite strand 374/376
(99 %)
5 diff
(98.7 %id)
BP396273 pancreatic islet .c 2027 to 2610 1 to 584     Submitted on the opposite strand 584/584
(100 %)
0 diff
(100 %id)
BP422673 small intestine .c 2034 to 2539 1 to 507     Submitted on the opposite strand 507/507
(100 %)
1 diff
(99.9 %id)
BE869567 adenocarcinoma, colon .c 2034 to 2212 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
BM968269 lung, Primary Lung Epithelial Cells .c 2048 to 2606 577 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 559/559
(100 %)
0 diff
(100 %id)
TI_154103666   .c 2059 to 2807 822 to 85   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 738/810
(91 %)
35 diff
(95.7 %id)
CU451028 epidermis .c 2067 to 2485 1 to 419       419/419
(100 %)
7 diff
(98.4 %id)
BG058572 blood, lymphocyte .c 2067 to 2605 539 to 1       539/539
(100 %)
4 diff
(99.3 %id)
BM695208 eye, optic nerve .c 2075 to 2341 1 to 268   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 268/268
(100 %)
1 diff
(99.7 %id)
AI820049 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 2097 to 2809 720 to 5       716/720
(99 %)
5 diff
(99.4 %id)
BM932106 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2102 to 2606 1 to 505   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 505/505
(100 %)
0 diff
(100 %id)
BM793113 Ascites, stomach .c 2104 to 2473 1 to 370       370/370
(100 %)
10 diff
(97.3 %id)
AA421748 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2115 to 2606 490 to 1       490/494
(99 %)
18 diff
(96.4 %id)
AI499419 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2115 to 2807 715 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 692/693
(99 %)
11 diff
(98.5 %id)
BF213699 bone marrow, from acute myelogenous leukemia .c 2127 to 2736 1 to 613       613/659
(93 %)
25 diff
(96.3 %id)
CK825074 Pancreas, Purified pancreatic islet .c 2130 to 2558 433 to 1     Submitted on the opposite strand 433/519
(83 %)
29 diff
(94.5 %id)
AA284019 germinal center B cell .c 2147 to 2425 1 to 279   fully sequenced,   279/279
(100 %)
4 diff
(98.6 %id)
AA688276 germinal center B cell .c 2163 to 2615 450 to 1       450/450
(100 %)
4 diff
(99.2 %id)
T64870 liver and spleen .c 2168 to 2601 441 to 8       434/441
(98 %)
0 diff
(100 %id)
BG182345   .c 2183 to 2477 21 to 315       299/315
(94 %)
6 diff
(98.1 %id)
BG187686   .c 2184 to 2816 37 to 665       630/846
(74 %)
45 diff
(94.7 %id)
BG217222   .c 2184 to 2971 792 to 12     Submitted on the opposite strand 781/815
(95 %)
8 diff
(99.1 %id)
T67438 liver and spleen .c 2184 to 2600 444 to 10       433/457
(94 %)
19 diff
(95.9 %id)
AA761405 germinal center B cell .c 2184 to 2615 431 to 1       431/440
(97 %)
5 diff
(98.9 %id)
BG183896   .c 2188 to 2975 1 to 784       784/809
(96 %)
37 diff
(95.5 %id)
BG187685   .c 2188 to 2971 1 to 778       778/803
(96 %)
14 diff
(98.3 %id)
BG214034   .c 2188 to 2950 1 to 756       756/798
(94 %)
13 diff
(98.4 %id)
BG215653   .c 2188 to 2606 1 to 419   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 419/419
(100 %)
7 diff
(98.4 %id)
AL042008 testis .c 2216 to 2816 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
R58865   .c 2228 to 2606 380 to 1       380/380
(100 %)
1 diff
(99.8 %id)
AU149876   .c 2248 to 2610 364 to 2       363/364
(99 %)
1 diff
(99.8 %id)
AL042032 testis .c 2259 to 2807 559 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 549/549
(100 %)
0 diff
(100 %id)
T40471 lung .c 2268 to 2607 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AA521150 germinal center B cell .c 2268 to 2807 566 to 27   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 540/540
(100 %)
13 diff
(97.6 %id)
AL562539 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 2280 to 2779 501 to 1   fully sequenced,   501/501
(100 %)
2 diff
(99.7 %id)
BM666384 eye, optic nerve .c 2280 to 2814 553 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 535/535
(100 %)
0 diff
(100 %id)
BM684020 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2280 to 2606 345 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 327/327
(100 %)
0 diff
(100 %id)
BM685115 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2280 to 2606 345 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 327/327
(100 %)
0 diff
(100 %id)
BG184440   .c 2288 to 2957 15 to 680       666/729
(91 %)
35 diff
(95.2 %id)
AW972110   .c 2304 to 2811 508 to 1     Submitted on the opposite strand 508/602
(84 %)
4 diff
(99.4 %id)
BG208886   .c 2309 to 2983 688 to 11     Submitted on the opposite strand 678/834
(81 %)
8 diff
(99.1 %id)
AU157904 placenta .c 2309 to 2814 507 to 1       507/593
(85 %)
7 diff
(98.9 %id)
BG208885   .c 2323 to 2606 1 to 284   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 284/284
(100 %)
8 diff
(97.2 %id)
BU589064 mixed (pool of 40 RNAs) .c 2326 to 2807 1 to 483       483/520
(92 %)
4 diff
(99.3 %id)
DB524735 testis .c 2356 to 2807 1 to 452   AAA Submitted on the opposite strand 452/452
(100 %)
1 diff
(99.8 %id)
DB529843 hippocampus .c 2393 to 2812 6 to 427     Submitted on the opposite strand 422/427
(98 %)
6 diff
(98.6 %id)
AI039274   .c 2394 to 2812 430 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 420/420
(100 %)
1 diff
(99.8 %id)
AA285153 germinal center B cell .c 2395 to 2816 422 to 1   fully sequenced,   422/422
(100 %)
6 diff
(98.6 %id)
CA445890 Chondrosarcoma, Left Pelvis .c 2400 to 2807 427 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
AI698363 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2402 to 2610 209 to 1       209/209
(100 %)
1 diff
(99.6 %id)
AI025833 parathyroid gland, parathyroid tumor .c 2411 to 2814 422 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
BG216712   .c 2431 to 2734 34 to 335       302/335
(90 %)
10 diff
(97.1 %id)
BQ325310 colon_ins .c 2436 to 2714 1 to 283       283/288
(98 %)
6 diff
(98.0 %id)
BQ325384 colon_ins .c 2441 to 2729 9 to 301       293/304
(96 %)
21 diff
(93.1 %id)
BQ325399 colon_ins .c 2441 to 2717 34 to 316       283/316
(89 %)
6 diff
(98.2 %id)
BQ325403 colon_ins .c 2441 to 2717 281 to 1       281/292
(96 %)
18 diff
(93.9 %id)
BQ325411 colon_ins .c 2443 to 2717 14 to 284       271/284
(95 %)
6 diff
(97.9 %id)
BQ323105 colon_est .c 2445 to 2729 1 to 285       285/288
(98 %)
14 diff
(95.2 %id)
BQ325366 colon_ins .c 2445 to 2729 1 to 288       288/291
(98 %)
16 diff
(94.6 %id)
BQ325407 colon_ins .c 2446 to 2729 300 to 18       283/301
(94 %)
0 diff
(100 %id)
BG188643   .c 2457 to 2970 527 to 14     Submitted on the opposite strand 514/921
(55 %)
0 diff
(100 %id)
BQ325385 colon_ins .c 2459 to 2711 1 to 260       260/266
(97 %)
26 diff
(90.3 %id)
BQ323098 colon_est .c 2476 to 2727 1 to 253       253/258
(98 %)
10 diff
(96.2 %id)
CN393404 embryonic stem cells, DMSO-treated H9 cellline .c 2484 to 3021 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
AI090248 uterus .c 2489 to 2990 502 to 1       502/502
(100 %)
0 diff
(100 %id)
BQ323143 colon_est .c 2492 to 2670 11 to 191       181/193
(93 %)
19 diff
(90.2 %id)
AW090185 brain, tumor, 5 pooled (see description) .c 2514 to 2988 475 to 1       475/475
(100 %)
3 diff
(99.4 %id)
AW895501 nervous_normal .c 2534 to 2871 342 to 6       337/342
(98 %)
0 diff
(100 %id)
AI220192 pooled .c 2538 to 2813 280 to 5       276/280
(98 %)
0 diff
(100 %id)
BX096185 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2558 to 2807 264 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 250/250
(100 %)
1 diff
(99.6 %id)
BU589804 mixed (pool of 40 RNAs) .c 2568 to 2807 1 to 240   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 240/240
(100 %)
3 diff
(98.8 %id)
AI223971 lymph node, lymphoma, follicular mixed small and largecell .c 2586 to 2988 401 to 1       401/401
(100 %)
2 diff
(99.6 %id)
BQ325371 colon_ins .c 2611 to 2717 107 to 1       107/107
(100 %)
3 diff
(97.2 %id)
FN175862 breast carcinoma .c 2639 to 2762 1 to 125       125/125
(100 %)
1 diff
(99.2 %id)
FN151876 breast carcinoma .c 2676 to 2779 1 to 103       103/104
(99 %)
2 diff
(98.1 %id)
EC534006 Prostate .c 2677 to 2781 1 to 104       104/104
(100 %)
1 diff
(99.1 %id)
EC534146 Prostate .c 2677 to 2781 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
EC562704 Prostate .c 2677 to 2781 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
FN090462 breast carcinoma .c 2704 to 2778 75 to 1     Submitted on the opposite strand 75/75
(100 %)
0 diff
(100 %id)
TI_151811442   .c 2707 to 3318 77 to 689   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 613/613
(100 %)
22 diff
(96.5 %id)
BM724671 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 2708 to 3317 1 to 610   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 610/610
(100 %)
1 diff
(99.9 %id)
TI_151764176   .c 2769 to 3322 639 to 86   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 554/554
(100 %)
17 diff
(97.0 %id)
AA781142   .c 2771 to 3318 556 to 9       548/556
(98 %)
0 diff
(100 %id)
AU153792   .c 2782 to 3318 540 to 1       540/564
(95 %)
17 diff
(97.0 %id)
AW873327 carcinoid, lung .c 2791 to 3316 526 to 1       526/526
(100 %)
2 diff
(99.7 %id)
BE466680 pooled germ cell tumors .c 2824 to 3318 514 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 495/495
(100 %)
2 diff
(99.6 %id)
BF194931 Kidney .c 2824 to 3320 516 to 21   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 496/496
(100 %)
9 diff
(98.2 %id)
DB572266 hypothalamus .c 2846 to 3317 1 to 472     Submitted on the opposite strand 472/477
(98 %)
1 diff
(99.8 %id)
AI986141 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2851 to 3321 474 to 3       472/474
(99 %)
0 diff
(100 %id)
AA740862 germinal center B cell .c 2852 to 3239 390 to 2       389/390
(99 %)
0 diff
(100 %id)
AW183150 pooled .c 2856 to 3320 477 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 465/465
(100 %)
0 diff
(100 %id)
DA776693 brain .c 2860 to 3446 2 to 589   tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
BE464613 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 2861 to 3320 472 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 460/474
(97 %)
0 diff
(100 %id)
AW779867 Kidney .c 2897 to 3312 425 to 10       416/425
(97 %)
0 diff
(100 %id)
FN065137 breast carcinoma .c 2912 to 3004 109 to 15     Submitted on the opposite strand 95/112
(84 %)
0 diff
(100 %id)
AI283608 pooled .c 2916 to 3319 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AA454934.
matches multiple genes
germinal center B cell .c 2921 to 3320 419 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base), also hits gene FAM122B 402/402
(100 %)
4 diff
(99.1 %id)
FN117526 breast carcinoma .c 2923 to 3048 128 to 4     Submitted on the opposite strand 125/128
(97 %)
0 diff
(100 %id)
AA836810 Kidney, kidney tumor .c 2970 to 3318 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AA911678 pooled .c 2970 to 3318 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
AI025468   .c 2977 to 3321 357 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 345/345
(100 %)
1 diff
(99.8 %id)
AI912060 carcinoid, lung .c 3025 to 3309 294 to 10       285/294
(96 %)
0 diff
(100 %id)
AI698072 carcinoid, lung .c 3025 to 3318 294 to 1       294/294
(100 %)
1 diff
(99.7 %id)
BQ695246 adipose .c 3090 to 3323 1 to 233       233/236
(98 %)
10 diff
(95.8 %id)
GD143556   .c 3181 to 3318 1 to 138   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 138/138
(100 %)
1 diff
(99.3 %id)
CD643519 Embryonic Stem cells .c 3329 to 4117 12 to 794   tiling clone,   783/855
(91 %)
12 diff
(98.6 %id)
AK025613   .c 3406 to 6379 1 to 2968   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2968/2968
(100 %)
5 diff
(99.9 %id)
DW430379 Liver .c 4747 to 5004 272 to 14       259/272
(95 %)
0 diff
(100 %id)
BX118038 germinal center B cell .c 4846 to 5621 1 to 776       776/776
(100 %)
4 diff
(99.5 %id)
AW968569   .c 5654 to 6397 742 to 1     Submitted on the opposite strand 742/743
(99 %)
11 diff
(98.6 %id)
FN168858 breast carcinoma .c 5743 to 5842 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
CN361020 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5832 to 6402 1 to 568       568/568
(100 %)
9 diff
(98.5 %id)
AI762031 B-cell, chronic lymphotic leukemia .c 5870 to 6392 519 to 1       519/519
(100 %)
6 diff
(98.9 %id)
AA604249 adrenal adenoma, adrenal gland .c 5883 to 6396 511 to 1       511/511
(100 %)
3 diff
(99.5 %id)
AW135818   .c 5888 to 6410 515 to 1       515/515
(100 %)
5 diff
(99.1 %id)
AA808764 germinal center B cell .c 5919 to 6408 486 to 1       486/486
(100 %)
3 diff
(99.4 %id)
BM150697 leukopheresis .c 5925 to 6412 483 to 1       483/483
(100 %)
6 diff
(98.8 %id)
AI681102 carcinoid, lung .c 5929 to 6400 469 to 1   tiling clone,   469/469
(100 %)
3 diff
(99.4 %id)
TI_151771192   .c 5945 to 6412 108 to 576   tiling clone, AAA   469/959
(48 %)
3 diff
(99.7 %id)
FN048485 breast carcinoma .c 5969 to 6036 1 to 69       69/70
(98 %)
2 diff
(97.2 %id)
BF594377 colon, colon tumor, RER+ .c 5973 to 6397 421 to 1       421/421
(100 %)
2 diff
(99.6 %id)
AA465704 germinal center B cell .c 6001 to 6398 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
BM151113 leukopheresis .c 6002 to 6412 407 to 2       406/407
(99 %)
0 diff
(100 %id)
BE858024 Prostate .c 6061 to 6392 332 to 1       332/335
(99 %)
1 diff
(99.8 %id)
BE244997 leukopheresis .c 6074 to 6379 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AA861458   .c 6112 to 6389 279 to 2       278/279
(99 %)
0 diff
(100 %id)
AA860278   .c 6171 to 6389 220 to 2       219/220
(99 %)
0 diff
(100 %id)
FN137488 breast carcinoma .c 6238 to 6333 1 to 94       94/94
(100 %)
3 diff
(96.9 %id)
AL043672 testis .d 1 to 536 1 to 536   tiling clone,   536/536
(100 %)
0 diff
(100 %id)
AL043673 testis .d 1378 to 2034 657 to 1   tiling clone,   657/657
(100 %)
0 diff
(100 %id)
N87855   .d 1607 to 1760 1 to 154       154/154
(100 %)
4 diff
(97.5 %id)
AL833947 testis .e 1 to 2749 1 to 2749 exact available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2749/2749
(100 %)
1 diff
(100.0 %id)
AL834150 testis .e 1 to 2749 1 to 2749   available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2749/2749
(100 %)
1 diff
(100.0 %id)
NR_033234.1   .e 1 to 6340 1 to 6340 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 6340/6340
(100 %)
0 diff
(100 %id)
DA505775 brain .e 7 to 348 2 to 343   capped   342/342
(100 %)
0 diff
(100 %id)
CN393402 embryonic stem cells, DMSO-treated H9 cellline .e 54 to 450 1 to 397       397/397
(100 %)
4 diff
(99.0 %id)
DB167249 kidney, tumor tissue .f 1 to 599 2 to 600   tiling clone, capped   599/599
(100 %)
1 diff
(99.9 %id)
BG529357 embryonal carcinoma, testis .f 594 to 1246 1 to 661   tiling clone,   661/890
(74 %)
19 diff
(97.9 %id)
CR596677 T cells (Jurkat cell line) Cot10-normalized .f 757 to 2204 1 to 1448   tiling clone,   1448/1448
(100 %)
0 diff
(100 %id)
BX345980   .f 757 to 1492 1 to 733   fully sequenced,   733/733
(100 %)
1 diff
(99.9 %id)
BX345979   .f 1462 to 2204 744 to 1   fully sequenced,   744/744
(100 %)
4 diff
(99.5 %id)
H23351 whole brain .g 1 to 398 1 to 406   tiling clone,   406/415
(97 %)
14 diff
(96.7 %id)
BE537415 cervix .g 132 to 898 1 to 769   tiling clone,   769/799
(96 %)
18 diff
(97.8 %id)
DB527936 testis .g 683 to 1174 1 to 493   tiling clone, Submitted on the opposite strand 493/497
(99 %)
9 diff
(98.2 %id)
H23240 whole brain .g 717 to 979 269 to 1   tiling clone,   269/447
(60 %)
5 diff
(98.9 %id)
BX460598 brain, fetal brain .h 1 to 808 4 to 811   tiling clone,   811/814
(99 %)
2 diff
(99.8 %id)
DA305238 hippocampus .h 508 to 1081 2 to 576   tiling clone, capped   575/575
(100 %)
2 diff
(99.7 %id)
CR749230 Liver .i-u 1 to 5979 1 to 5984   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 5984/5984
(100 %)
7 diff
(99.9 %id)
NR_026677.1   .i-u 1 to 5983 1 to 5983 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 5983/5983
(100 %)
0 diff
(100 %id)
BF879954 lung_tumor .i-u 104 to 572 498 to 30     Submitted on the opposite strand 469/498
(94 %)
0 diff
(100 %id)
CN283503 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i-u 118 to 750 6 to 638       633/638
(99 %)
6 diff
(99.1 %id)
BX648949 human amygdala .i-u 360 to 5979 1 to 5626 S90G available from DKFZ, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 5626/5626
(100 %)
15 diff
(99.8 %id)
BG116998 duodenal adenocarcinoma, cell line, small intestine .i-u 763 to 1453 1 to 707       707/1143
(61 %)
9 diff
(99.3 %id)
CN335339 embryonic stem cells, cell lines H1, H7, andH9 .i-u 1526 to 2226 1 to 702       702/702
(100 %)
2 diff
(99.8 %id)
CN289614 embryonic stem cells, DMSO-treated H9 cellline .i-u 1622 to 1838 1 to 217       217/217
(100 %)
0 diff
(100 %id)
BF929107 nervous_tumor .i-u 1760 to 1924 183 to 19     Submitted on the opposite strand 165/183
(90 %)
0 diff
(100 %id)
AW842889 colon_normal .i-u 1800 to 2010 1 to 211       211/211
(100 %)
3 diff
(98.6 %id)
DB070573 testis .i-u 1895 to 2443 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA398707 thalamus .i-u 1949 to 2479 2 to 534   capped   533/533
(100 %)
4 diff
(99.3 %id)
BC015678 Placenta, choriocarcinoma .i-u 2011 to 5981 1 to 3971 exact available from MGC, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 3971/3971
(100 %)
1 diff
(100.0 %id)
DB098838 testis .i-u 2270 to 2838 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
AK123844   .i-u 2271 to 5979 1 to 3709 exact available from FLJ,   3709/3709
(100 %)
3 diff
(100.0 %id)
DA461856 tongue, tumor tissue .i-u 2272 to 2821 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA722836   .i-u 2272 to 2828 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB133232 thymus .i-u 2272 to 2844 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA189013 amygdala .i-u 2274 to 2819 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DA233096 brain .i-u 2276 to 2859 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DA220387 brain .i-u 2278 to 2836 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA319176 hippocampus .i-u 2278 to 2838 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB150960 thymus .i-u 2446 to 2919 2 to 482   capped   481/481
(100 %)
4 diff
(99.2 %id)
DB165367 thymus .i-u 2452 to 3030 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
TI_57229689   .i-u 2518 to 3137 81 to 707       627/627
(100 %)
4 diff
(99.4 %id)
BI871093 adenocarcinoma, cell line, Liver .i-u 2519 to 3137 1 to 626       626/626
(100 %)
4 diff
(99.4 %id)
DA728049   .i-u 2627 to 3282 2 to 660   capped   659/661
(99 %)
8 diff
(98.8 %id)
DA414765 thalamus .i-u 2750 to 3303 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
DA112718 cerebellum .i-u 2767 to 3364 2 to 598   capped   597/597
(100 %)
3 diff
(99.5 %id)
DA202467 brain .i-u 2781 to 3332 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
AK025814   .i-u 2839 to 5983 1 to 3145 exact available from FLJ, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 3145/3145
(100 %)
6 diff
(99.9 %id)
AI124854 brain, pooled frontal lobe .i-u 2861 to 3265 405 to 1       405/405
(100 %)
2 diff
(99.6 %id)
DA197497 brain .i-u 2888 to 3387 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
DB079245 testis .i-u 2908 to 3435 2 to 530   capped   529/531
(99 %)
2 diff
(99.7 %id)
DA495092 brain .i-u 2954 to 3490 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA309027 hippocampus .i-u 3168 to 3734 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CB156640 brain .i-u 3474 to 3978 1 to 505       505/505
(100 %)
4 diff
(99.3 %id)
BY797131 eye .i-u 3506 to 4079 25 to 598       574/598
(95 %)
6 diff
(99.0 %id)
BM909590 lymph, lymphoma, cell line .i-u 3536 to 4182 27 to 674       648/1084
(59 %)
6 diff
(99.5 %id)
BQ642737 lymph, lymphoma, cell line .i-u 3536 to 4315 1 to 787       787/947
(83 %)
39 diff
(95.9 %id)
BQ059190 lymph, lymphoma, cell line .i-u 3537 to 4353 1 to 820       820/1002
(81 %)
25 diff
(97.6 %id)
BM006188 hepatocellular carcinoma, cell line, Liver .i-u 3638 to 4140 1 to 501       501/557
(89 %)
5 diff
(99.2 %id)
BM006027 hepatocellular carcinoma, cell line, Liver .i-u 3638 to 4116 1 to 489       489/513
(95 %)
17 diff
(96.7 %id)
TI_59385980   .i-u 3639 to 4062 65 to 491       427/512
(83 %)
15 diff
(97.1 %id)
TI_59386144   .i-u 3639 to 4140 118 to 617       500/556
(89 %)
5 diff
(99.2 %id)
BM928204 hepatocellular carcinoma, cell line, Liver .i-u 3641 to 4562 1 to 931       931/1076
(86 %)
17 diff
(98.5 %id)
BQ648248 hepatocellular carcinoma, cell line, Liver .i-u 3641 to 4526 1 to 896       896/940
(95 %)
38 diff
(96.0 %id)
DA783479 brain .i-u 3673 to 4252 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA913478   .i-u 3980 to 4537 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BQ066089 lymph, lymphoma, cell line .i-u 4021 to 4779 1 to 766       766/1081
(70 %)
15 diff
(98.7 %id)
BC034918 Lymph, Burkitt lymphoma .i-u 4049 to 5979 1 to 1931 exact available from MGC, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 1931/1931
(100 %)
1 diff
(100.0 %id)
DA250254 caudate nucleus .i-u 4050 to 4610 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BE267811 Burkitt lymphoma, lymph .i-u 4068 to 4704 1 to 650   available from MGC,   650/650
(100 %)
21 diff
(96.8 %id)
BM721286 eye, fetal eye .i-u 4093 to 4706 1 to 614     Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
DA934815 Spleen .i-u 4143 to 4664 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA063474 cerebellum .i-u 4144 to 4703 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BP349699 brain .i-u 4286 to 4869 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
AA350588 brain .i-u 4312 to 4735 1 to 423       423/423
(100 %)
2 diff
(99.6 %id)
AF251293 Liver .i-u 4312 to 5980 1 to 1669 exact AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 1669/1671
(99 %)
4 diff
(99.8 %id)
AW953272   .i-u 4316 to 4525 1 to 210       210/210
(100 %)
10 diff
(95.3 %id)
DN994484 brain, whole brain .i-u 4460 to 5035 2 to 578 exact     577/578
(99 %)
6 diff
(99.0 %id)
BX280804 cervix .i-u 4566 to 5046 1 to 481       481/481
(100 %)
0 diff
(100 %id)
BE540389 cervix .i-u 4574 to 5316 1 to 740       740/843
(87 %)
21 diff
(97.6 %id)
R61665 whole brain .i-u 4590 to 4975 1 to 388     Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 388/391
(99 %)
4 diff
(99.0 %id)
R52380 whole brain .i-u 4597 to 5068 1 to 478     Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 478/489
(97 %)
8 diff
(98.4 %id)
BM728734 eye, fetal eye .i-u 4721 to 5418 1 to 698     Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 698/698
(100 %)
0 diff
(100 %id)
CN335340 embryonic stem cells, cell lines H1, H7, andH9 .i-u 4833 to 5390 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
AJ420426   .i-u 4838 to 5983 9 to 1154   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 1146/1154
(99 %)
6 diff
(99.5 %id)
CB155220 brain .i-u 4845 to 5347 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
AA477801 ovarian tumor, ovary .i-u 4905 to 5221 1 to 316       316/316
(100 %)
4 diff
(98.8 %id)
AA482651 ovarian tumor, ovary .i-u 4905 to 5253 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
F12735 brain, total brain .i-u 4993 to 5288 1 to 296       296/296
(100 %)
1 diff
(99.7 %id)
H14971 whole brain .i-u 4995 to 5434 1 to 444       444/453
(98 %)
9 diff
(98.1 %id)
CN335338 embryonic stem cells, DMSO-treated H9 cellline .i-u 5002 to 5623 1 to 623       623/623
(100 %)
2 diff
(99.7 %id)
R13528 whole brain .i-u 5020 to 5456 1 to 446     Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 446/447
(99 %)
23 diff
(94.9 %id)
BG107710 Bone, osteosarcoma, cell line .i-u 5147 to 5350 1 to 204       204/204
(100 %)
0 diff
(100 %id)
D80912 brain .i-u 5148 to 5594 1 to 445       445/445
(100 %)
3 diff
(99.4 %id)
D60473 brain .i-u 5149 to 5402 1 to 262       262/265
(98 %)
7 diff
(97.4 %id)
TI_151756823   .i-u 5218 to 5983 855 to 100   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 756/878
(86 %)
10 diff
(98.9 %id)
BU730467 eye, RPE and Choroid .i-u 5264 to 5983 737 to 19   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 719/722
(99 %)
7 diff
(99.1 %id)
BM694330 eye, RPE and Choroid .i-u 5272 to 5699 1 to 428       428/428
(100 %)
0 diff
(100 %id)
BM704833 eye, RPE and Choroid .i-u 5272 to 5672 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BQ225956 embryonal carcinoma, cell line, testis .i-u 5294 to 5887 39 to 636       598/1245
(48 %)
6 diff
(99.6 %id)
DB111415 thymus .i-u 5294 to 5687 2 to 395   capped   394/567
(69 %)
2 diff
(99.7 %id)
BM677019 eye, fetal eye .i-u 5309 to 5977 687 to 19   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 669/669
(100 %)
0 diff
(100 %id)
BQ002726 Chondrosarcoma, Left Pelvis .i-u 5312 to 5979 683 to 17   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 667/667
(100 %)
1 diff
(99.9 %id)
CA422845 cell lines, Chondrosarcoma .i-u 5321 to 5977 675 to 19   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
TI_149302078   .i-u 5355 to 5977 676 to 58   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 619/800
(77 %)
21 diff
(97.4 %id)
BE697387 colon .i-u 5394 to 5942 558 to 7       552/564
(97 %)
0 diff
(100 %id)
DB324300   .i-u 5417 to 5979 563 to 1       563/565
(99 %)
2 diff
(99.7 %id)
AI651608 pooled germ cell tumors .i-u 5441 to 5978 540 to 3       538/540
(99 %)
0 diff
(100 %id)
BM471903 eye, retinoblastoma .i-u 5447 to 5983 10 to 546   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 537/546
(98 %)
6 diff
(99.0 %id)
R60997 whole brain .i-u 5456 to 5979 567 to 21   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 547/553
(98 %)
34 diff
(93.9 %id)
AA179438   .i-u 5458 to 5707 1 to 248   fully sequenced,   248/248
(100 %)
2 diff
(99.2 %id)
R20650 whole brain .i-u 5462 to 5976 538 to 31   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 508/509
(99 %)
22 diff
(95.7 %id)
DB303783 brain .i-u 5463 to 5983 523 to 1       523/523
(100 %)
2 diff
(99.7 %id)
AW055268 serous papillary carcinoma, high grade, 2pooled tumors, uterus .i-u 5470 to 5979 510 to 1       510/510
(100 %)
0 diff
(100 %id)
BX283013 whole brain .i-u 5478 to 5942 470 to 6     Submitted on the opposite strand 465/470
(98 %)
0 diff
(100 %id)
CR745142   .i-u 5478 to 5942 470 to 6     Submitted on the opposite strand 465/470
(98 %)
0 diff
(100 %id)
AI697287 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .i-u 5478 to 5983 506 to 1       506/506
(100 %)
0 diff
(100 %id)
AW590278 pooled germ cell tumors .i-u 5491 to 5973 487 to 5       483/487
(99 %)
0 diff
(100 %id)
AA741505 germinal center B cell .i-u 5493 to 5979 498 to 12   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
AA477802 ovarian tumor, ovary .i-u 5515 to 5979 465 to 1       465/466
(99 %)
0 diff
(100 %id)
BU742655 eye, fetal eye .i-u 5522 to 5977 474 to 19   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
AI471625 Kidney .i-u 5534 to 5979 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AI052160 liver and spleen .i-u 5540 to 5983 444 to 1       444/444
(100 %)
0 diff
(100 %id)
R52381 whole brain .i-u 5559 to 5979 436 to 20   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 417/417
(100 %)
12 diff
(97.2 %id)
AA811095 germinal center B cell .i-u 5562 to 5978 425 to 9       417/429
(97 %)
0 diff
(100 %id)
D80846 brain .i-u 5592 to 5983 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AI668819 Prostate .i-u 5606 to 5988 391 to 9       383/391
(97 %)
0 diff
(100 %id)
D60540 brain .i-u 5608 to 5983 375 to 1       375/382
(98 %)
3 diff
(99.3 %id)
BM980339 lung, Primary Lung Cystic Fibrosis EpithelialCells .i-u 5610 to 5977 387 to 19   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 369/369
(100 %)
1 diff
(99.8 %id)
CN335341 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i-u 5614 to 5977 1 to 364   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 364/364
(100 %)
0 diff
(100 %id)
D60423   .i-u 5615 to 5983 369 to 1       369/369
(100 %)
2 diff
(99.5 %id)
AA350587 brain .i-u 5651 to 5979 329 to 1       329/329
(100 %)
0 diff
(100 %id)
F10341 brain, total brain .i-u 5673 to 5977 305 to 1       305/305
(100 %)
1 diff
(99.7 %id)
AA179294   .i-u 5677 to 5986 313 to 1   fully sequenced,   313/313
(100 %)
2 diff
(99.4 %id)
H14972 whole brain .i-u 5694 to 5972 292 to 1       292/304
(96 %)
16 diff
(94.8 %id)
AI699443 pooled .i-u 5725 to 5978 256 to 3       254/256
(99 %)
0 diff
(100 %id)
AW235951 Kidney .i-u 5726 to 5979 254 to 1       254/254
(100 %)
3 diff
(98.9 %id)
AA890564 parathyroid gland, parathyroid tumor .i-u 5759 to 5978 225 to 6       220/225
(97 %)
0 diff
(100 %id)
AI579917 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .i-u 5780 to 5988 212 to 4       209/212
(98 %)
0 diff
(100 %id)
DA527341 brain .j 1 to 594 2 to 596 F54V C55L H56P V57C D58* tiling clone, capped   595/595
(100 %)
1 diff
(99.9 %id)
DB459253 testis .j 30 to 504 1 to 475   tiling clone,   475/475
(100 %)
1 diff
(99.8 %id)
AI699420 pooled .k 1 to 286 288 to 3 exact tiling clone,   286/296
(96 %)
0 diff
(100 %id)
CN414454 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l-u 1 to 756 1 to 757   tiling clone,   757/757
(100 %)
6 diff
(99.3 %id)
BE675701 B-cell, chronic lymphotic leukemia .l-u 270 to 746 478 to 2       477/478
(99 %)
0 diff
(100 %id)
DA947898 Spleen .l-u 501 to 1059 2 to 561   tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
AK024960 colon .l-u 803 to 2930 1 to 2128 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2128/2128
(100 %)
5 diff
(99.8 %id)
BM834936 stomach .l-u 1937 to 2406 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BE244314 leukopheresis .l-u 2275 to 2616 1 to 341       341/341
(100 %)
2 diff
(99.5 %id)
BM153085 leukopheresis .l-u 2275 to 2727 1 to 453   tiling clone,   453/453
(100 %)
2 diff
(99.6 %id)
BE244963 leukopheresis .l-u 2275 to 2722 1 to 448       448/448
(100 %)
1 diff
(99.8 %id)
AA829259 germinal center B cell .l-u 2567 to 2932 366 to 1   tiling clone,   366/366
(100 %)
1 diff
(99.8 %id)
BQ430396 embryonal carcinoma, cell line, testis .m 1 to 780 1 to 782 exact tiling clone,   782/902
(86 %)
10 diff
(98.9 %id)
BF948883 nervous_normal .n 1 to 436 441 to 1 H10Q N36E A37R S38K D39* tiling clone,   441/441
(100 %)
10 diff
(97.8 %id)
CV408109 colon .o-u 1 to 416 1 to 415 exact tiling clone,   415/415
(100 %)
5 diff
(98.8 %id)
BG461958   Gene STRBPandC9orf45, variant not shown         This clone was ignored    
AV646876 corresponding non cancerous liver tissue Gene STRBPandC9orf45, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV646880 corresponding non cancerous liver tissue Gene STRBPandC9orf45, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV647480 corresponding non cancerous liver tissue Gene STRBPandC9orf45, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AA224386 brain, neuroepithelial cells Gene STRBPandC9orf45, variant not shown         This clone was ignored    
AA224471 brain, neuroepithelial cells Gene STRBPandC9orf45, variant not shown         This clone was ignored    
AA234444 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene STRBPandC9orf45, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA236580 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene STRBPandC9orf45, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BI091162 cervix Gene STRBPandC9orf45, variant not shown         This clone was ignored    
BU158800 embryonal carcinoma, cell line, testis Gene STRBPandC9orf45, variant not shown         This clone was ignored    
DA787524 brain Gene STRBPandC9orf45, variant not shown       capped Suspected internal deletion, this clone was ignored    
TI_159696737   Gene STRBPandC9orf45, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM724921 eye, fetal eye Gene STRBPandC9orf45, variant not shown         This clone was ignored    
CN480696 Cell Line, Chondrosarcoma Gene STRBPandC9orf45, variant not shown       AAA This clone was ignored    
CA429292 Cell Line, Chondrosarcoma Gene STRBPandC9orf45, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l-u, .m, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI